Skip to main content
. 2017 Apr 24;61(5):e02000-16. doi: 10.1128/AAC.02000-16

FIG 1.

FIG 1

Plots of observed maximum concentrations of piperaquine from three clinical studies evaluating DP (2010 to 2013). Blue, red, and green symbols, data from the 2010, 2012, and 2013 studies, respectively; circles, 2DP regimen; diamonds, 3DP regimen; horizontal bars, median and interquartile ranges; value above each column, the median piperaquine concentration; red bars above the columns, individual comparisons of statistical significance (**, significant differences [P < 0.01]; ****, very highly significant differences [P < 0.0001]).